The American Diabetes Association (ADA) recently announced the winners of its Innovation Challenge competition at the 84th Scientific Sessions. Diatech Diabetes, Spotlight Communications, and Symbio Cell Tech were recognized for their groundbreaking ideas in the field of diabetes care.
With over 38 million Americans affected by diabetes, the need for innovative solutions is greater than ever. The ADA is proud to support emerging advancements in research and care for individuals living with diabetes.
Diatech Diabetes impressed the panel with its software platform designed to improve infusion failure detection in insulin pump systems. Spotlight Communications presented a clinical tool addressing patient concerns and mapping resources for overall wellbeing. Symbio Cell Tech showcased a biotherapy for type 1 diabetes patients.
Other finalists included Spect, offering a telemedicine platform for eye screening, and Valendo Health, addressing the shortage of endocrinologists through telehealth services. The competition highlights the growing market for diabetes startups and encourages further advancements in the field.
The ADA’s Scientific Sessions, held in Orlando, FL, brought together over 11,000 healthcare professionals and researchers to discuss the latest in diabetes research and care. The event showcased cutting-edge research and treatment recommendations, with a focus on finding a cure for diabetes.
The next Innovation Challenge will open for applications in January 2025, giving innovators an opportunity to showcase their ideas and contribute to the fight against diabetes. To learn more about the ADA’s mission and how to get involved, visit diabetes.org or call 1-800-DIABETES.
Follow the ADA on social media for updates and join the conversation using #ADAScientificSessions. Let’s work together to bend the curve on the diabetes epidemic and support those living with diabetes.
Source link